GlassScriptPhysician profile
Bridget Nicole Shaw
NPI 1285204719
$1,675.61
in general payments reported to CMS, 2019-2025
17 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $737 · 2023: $220 · 2024: $250 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $654 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $653.62 |
| Education | $285.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $268.46 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $249.99 | 2022-2025 | |
| Janssen Biotech, INC. | $171.48 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Amgen INC. | $162.23 | 2022-2025 | Otezla |
| Intuitive Surgical, INC. | $151.25 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2022 | |
| Janssen Scientific Affairs, LLC | $91.07 | 2022 | |
| Sun Pharmaceutical Industries INC. | $89.86 | 2023-2025 | Odomzo, Blu-U |
| Leo Pharma INC. | $71.51 | 2023-2025 | Anzupgo, Adbry |
| Pfizer INC. | $65.77 | 2022-2023 | |
| Abbvie INC. | $64.45 | 2022-2024 | |
| Galderma Laboratories, L.P. | $48.02 | 2025 | Nemluvio |
| Lilly USA, LLC | $39.80 | 2022-2025 | Ebglyss |
| Biofrontera INC. | $33.93 | 2022-2023 | Ameluz, Xepi, Bf-Rhodoled |
| E.R. Squibb & Sons, L.L.C. | $16.30 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $15.88 | 2024 | Zoryve |
| Incyte Corporation | $13.78 | 2023 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.